Skip to main content
Premium Trial:

Request an Annual Quote

Neogen Acquires Brazilian Animal Genomics Firm Deoxi

NEW YORK (GenomeWeb) – Food and animal safety firm Neogen announced today that it has acquired Brazilian animal genomics lab Deoxi Biotecnologia. 

Specific terms of the acquisition were not disclosed.

According to Neogen, the transaction is expected to accelerate adoption of its GeneSeek livestock genomic testing solutions in Brazil, which has an estimated 200 million cattle.

"Deoxi has excellent facilities and an excellent reputation with its customers [including] research institutions, universities, and animal breeding companies," Neogen Chairman and CEO James Herbert said in a statement. "Deoxi's management and staff will remain with the company and will continue their work to help Neogen grow the Brazilian genomics business."

Herbert added that samples from Neogen's Brazilian customers will now be proceeded at Deoxi's lab in that country, rather than being sent to Neogen's lab in Nebraska.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.